Galecto Inc

Biotech Stocks Healthcare Stocks

$25.26

+2.63 (+11.62%)

As of Feb 8, 2:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target -33.5% upside

Low Target $13.00

Average Target $16.81

High Target $24.93

Current Price $25.26

Current
$25.26

Target
$16.81

$13.00 $16.81 avg $24.93

Scenario Analysis

Bear Case

$13.00

-48.5%

Low target

Base Case

$16.81

-33.5%

Avg target

Bull Case

$24.93

+-1.3%

High target

Risk/Reward

0.0x

Unfavorable

Price in Context

52-Week High

$15.81

59.8% from high

52-Week Low

$9.81

+157.5% from low

Target vs 52W High

$16.81

+6.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%